Cas:247257-48-3 Fimasartan manufacturer & supplier

We serve Chemical Name:Fimasartan CAS:247257-48-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Fimasartan

Chemical Name:Fimasartan
CAS.NO:247257-48-3
Synonyms:2-(2-Butyl-4-methyl-6-oxo-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide;UNII-P58222188P;br-a-657k;Fimasartan;5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
Molecular Formula:C27H31N7OS
Molecular Weight:501.646
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:693.0±65.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.658
PSA:124.68000
Exact Mass:501.231079
LogP:4.53

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(2-Butyl-4-methyl-6-oxo-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-Butyl-4-methyl-6-oxo-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide Use and application,2-(2-Butyl-4-methyl-6-oxo-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide technical grade,usp/ep/jp grade.


Related News: Wavelength’s growth in the API space comes as nations around the world look to develop redundant supply chains for key generic medicines amid the pandemic. 2-(4-Methoxyphenyl)imidazo[1,2-a]pyrimidine manufacturers Here’s how Biogen did during the three months ended June 30 compared with what Wall Street expected, according to average estimates compiled by Refinitiv. 2,5-anhydro-d-mannitol-1-phosphate, barium salt hydrate suppliers Wavelength’s growth in the API space comes as nations around the world look to develop redundant supply chains for key generic medicines amid the pandemic. 9-(Aminomethyl)julolidine dihydrochloride vendor & factory As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders.,As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders.